Skip to main content

4884 · Kringle Pharma,Inc. · Financials

519 JPY -2 (-0.38%) At close · Nov 12
Market Cap
4.19B JPY
Shares
8.08M
Volume · Nov 12 317.6K Avg daily vol (3M) 276.91K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
72.22M -9.8%
FY2025 Revenue FY2021–FY2025
Net Income
-916.26M -21.1%
FY2025 Net Income FY2021–FY2025
Gross Margin
100% 0pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-1259.37% -237.5pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-755.78M -14.3%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 72.22M 80.04M 69.25M 391.83M 289.76M
JPY 72.22M 80.04M 69.25M 303.42M 218.16M
JPY -909.45M -817.88M -888.76M -426.17M -357.88M
JPY -914.76M -754.96M -852.66M -330.34M -299.68M
JPY 1.5M 1.49M 1.49M 1.49M 1.49M
JPY -916.26M -756.45M -854.15M -331.83M -301.17M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.